Jeff Elton

Jeff Elton

Jeff Elton's picture
Jeff Elton is a Managing Director of Accenture Life Sciences, with broad responsibilities for the strategy and partnerships for new solutions enabled by clinical data and analytics. Elton has more than 20 years of experience as a global executive and consultant in the biopharmaceutical and healthcare sectors. Prior to joining Accenture in 2011, Elton was founding CEO, board member and senior advisor to five early stage companies and has held senior positions at Novartis Institutes of BioMedical Research and McKinsey & Company. Elton sits on the boards of the Massachusetts Biotechnology Council and the Elizabeth Glaser Pediatric AIDS Foundation, where he is also an executive committee member. In addition, he teaches at the Boston University School of Management. Elton has an MBA in Finance and Statistics and Ph.D. in business economics and marketing from the University of Chicago Booth School of Business.

Latest posts from Jeff:

Column, Clinical

Personalized Medicine Can Lead To...

Aug 21, 2013

Jeff Elton explains how the need for more targeted, personalized therapies, are...

Column

Health Care...

May 21, 2013

Jeff Elton examines the collaborative, risk-sharing relationships necessary...

Column

Personalized Medicine: New...

Apr 17, 2013

As new personalized medicine technologies such as next generation sequencing...

Commercial

Note to Pharmacos: Regroup to...

Mar 22, 2013

Stakeholders, such as providers and payers, want pharma and biopharma companies...

Column

Personalized Medicine Brings Value...

Feb 20, 2013

Jeff Elton highlights the differing market access strategies for personalized...

Access and Evidence

New Infrastructure Is Needed to...

Feb 18, 2013

Developing and commercializing personalized medicine requires that top...

Column

Life Sciences Companies, Partners...

Jan 17, 2013

In today's market there are many masters to please when bringing a new...

Column

Making Personalized Medicine Value...

Nov 22, 2012

How personalized medicine becomes functional is key to making it practical and...

Column

Personalized Therapeutic...

Oct 17, 2012

Developing highly personalized, or targeted, therapeutics is one way to help...

Column

Value-Based Reimbursement Brings...

Sep 19, 2012

Value-based reimbursement will change the way life sciences companies decide...

Pages